{"id":"panzytrat-25-000-fip-e-units-of-lipase","safety":{"commonSideEffects":[{"rate":null,"effect":"Abdominal discomfort"},{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Diarrhea"},{"rate":null,"effect":"Constipation"}]},"_chembl":{"chemblId":"CHEMBL1201637","moleculeType":"Enzyme"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Lipase is a pancreatic enzyme that breaks down triglycerides and other lipids in the small intestine. In pancreatic insufficiency, endogenous lipase production is reduced, leading to malabsorption of fats and fat-soluble vitamins. Panzytrat supplements this deficiency by providing exogenous lipase to restore normal fat digestion and nutrient absorption.","oneSentence":"Panzytrat is a pancreatic enzyme replacement therapy containing lipase that aids in the digestion and absorption of dietary fats.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-27T23:59:43.038Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Pancreatic insufficiency (chronic pancreatitis, cystic fibrosis, pancreatic surgery)"},{"name":"Fat malabsorption disorders"}]},"trialDetails":[{"nctId":"NCT01430234","phase":"PHASE4","title":"Enzyme Suppletion in Exocrine Pancreatic Dysfunction","status":"COMPLETED","sponsor":"Foundation for Liver Research","startDate":"2011-10","conditions":"Chronic Pancreatitis, Exocrine Pancreatic Insufficiency","enrollment":10}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Pancreatine of porcine-origin"],"phase":"marketed","status":"active","brandName":"Panzytrat 25.000 FIP-E units of Lipase","genericName":"Panzytrat 25.000 FIP-E units of Lipase","companyName":"Foundation for Liver Research","companyId":"foundation-for-liver-research","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Panzytrat is a pancreatic enzyme replacement therapy containing lipase that aids in the digestion and absorption of dietary fats. Used for Pancreatic insufficiency (chronic pancreatitis, cystic fibrosis, pancreatic surgery), Fat malabsorption disorders.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}